Search results
EAN 2024: The role of B cells in shaping rituximab use in generalised MG
Clinical Trials Arena· 2 days agoFurther research is warranted to better understand the role that both rituximab and inebilizumab...
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena· 5 days agoAll treatment doses will be administered via subcutaneous injection. The trial will have an...
Roche’s Phase II/III NSCLC treatment trial fails to meet primary endpoints
Clinical Trials Arena· 3 days ago“We are thankful to all of the patients and healthcare professionals involved in the study, and we...
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 7 days agoStudy results are expected for two closely watched obesity drugs, while key tests await for a...
10 Essential Oils for Hair Growth and Health
Verywell Health· 5 days agoPeppermint Essential Oil Little to no human studies support peppermint...However, a study on mice found that peppermint essential oil produced thick,...
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 5 days ago“This is another positive sign of further progress, but we must keep moving forward until we reach the finish line — a cure for Alzheimer’s disease....
Safer And Cheaper Ozempic Alternatives Over The Counter For Losing Weight - Natural OTC Semaglutide...
Outlook India· 3 days agoA herbal hunger reducer that works in a similar way to Ozempic is Zotrim - naturally formulated and...
This viral low cost alternative to Ozempic can (apparently) aid weight loss just as effectively
Indian Express· 5 days agoBrown rice is a notable source of dietary fibre, says Dr Vinutha, a type of carbohydrate that the...
EAN 2024: Benefits of early migraine treatment clear but implementation remains challenging
Clinical Trials Arena· 4 days agoA further key challenge highlighted during the symposium is that due to the variability of migraine...
Eli Lilly Alzheimer's drug approved by US FDA - ET HealthWorld | Pharma
The Economic Times· 4 days agoThe approval for donanemab, to be sold under the brand name Kisunla, followed the recommendations of...
